207 related articles for article (PubMed ID: 23108411)
1. MUC1 enhances hypoxia-driven angiogenesis through the regulation of multiple proangiogenic factors.
Kitamoto S; Yokoyama S; Higashi M; Yamada N; Takao S; Yonezawa S
Oncogene; 2013 Sep; 32(39):4614-21. PubMed ID: 23108411
[TBL] [Abstract][Full Text] [Related]
2. The reactive tumor microenvironment: MUC1 signaling directly reprograms transcription of CTGF.
Behrens ME; Grandgenett PM; Bailey JM; Singh PK; Yi CH; Yu F; Hollingsworth MA
Oncogene; 2010 Oct; 29(42):5667-77. PubMed ID: 20697347
[TBL] [Abstract][Full Text] [Related]
3. GPER in CAFs regulates hypoxia-driven breast cancer invasion in a CTGF-dependent manner.
Ren J; Guo H; Wu H; Tian T; Dong D; Zhang Y; Sui Y; Zhang Y; Zhao D; Wang S; Li Z; Zhang X; Liu R; Qian J; Wei H; Jiang W; Liu Y; Li Y
Oncol Rep; 2015 Apr; 33(4):1929-37. PubMed ID: 25647524
[TBL] [Abstract][Full Text] [Related]
4. Hypoxia stimulates pancreatic stellate cells to induce fibrosis and angiogenesis in pancreatic cancer.
Masamune A; Kikuta K; Watanabe T; Satoh K; Hirota M; Shimosegawa T
Am J Physiol Gastrointest Liver Physiol; 2008 Oct; 295(4):G709-17. PubMed ID: 18669622
[TBL] [Abstract][Full Text] [Related]
5. MUC1 regulates PDGFA expression during pancreatic cancer progression.
Sahraei M; Roy LD; Curry JM; Teresa TL; Nath S; Besmer D; Kidiyoor A; Dalia R; Gendler SJ; Mukherjee P
Oncogene; 2012 Nov; 31(47):4935-45. PubMed ID: 22266848
[TBL] [Abstract][Full Text] [Related]
6. Erythropoietin is involved in the angiogenic potential of bone marrow macrophages in multiple myeloma.
De Luisi A; Binetti L; Ria R; Ruggieri S; Berardi S; Catacchio I; Racanelli V; Pavone V; Rossini B; Vacca A; Ribatti D
Angiogenesis; 2013 Oct; 16(4):963-73. PubMed ID: 23881169
[TBL] [Abstract][Full Text] [Related]
7. Glioblastoma-derived leptin induces tube formation and growth of endothelial cells: comparison with VEGF effects.
Ferla R; Bonomi M; Otvos L; Surmacz E
BMC Cancer; 2011 Jul; 11():303. PubMed ID: 21771332
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of MUC1 enhances proangiogenic activity of non-small-cell lung cancer cells through activation of Akt and extracellular signal-regulated kinase pathways.
Yao M; Zhang W; Zhang Q; Xing L; Xu A; Liu Q; Cui B
Lung; 2011 Dec; 189(6):453-60. PubMed ID: 21959954
[TBL] [Abstract][Full Text] [Related]
9. Tumor escape from endogenous, extracellular matrix-associated angiogenesis inhibitors by up-regulation of multiple proangiogenic factors.
Fernando NT; Koch M; Rothrock C; Gollogly LK; D'Amore PA; Ryeom S; Yoon SS
Clin Cancer Res; 2008 Mar; 14(5):1529-39. PubMed ID: 18316578
[TBL] [Abstract][Full Text] [Related]
10. AGR2 expression is regulated by HIF-1 and contributes to growth and angiogenesis of glioblastoma.
Hong XY; Wang J; Li Z
Cell Biochem Biophys; 2013; 67(3):1487-95. PubMed ID: 23712868
[TBL] [Abstract][Full Text] [Related]
11. Plasmalemmal vesicle associated protein-1 is a novel marker implicated in brain tumor angiogenesis.
Carson-Walter EB; Hampton J; Shue E; Geynisman DM; Pillai PK; Sathanoori R; Madden SL; Hamilton RL; Walter KA
Clin Cancer Res; 2005 Nov; 11(21):7643-50. PubMed ID: 16278383
[TBL] [Abstract][Full Text] [Related]
12. Cell type-specific regulation of angiogenic growth factor gene expression and induction of angiogenesis in nonischemic tissue by a constitutively active form of hypoxia-inducible factor 1.
Kelly BD; Hackett SF; Hirota K; Oshima Y; Cai Z; Berg-Dixon S; Rowan A; Yan Z; Campochiaro PA; Semenza GL
Circ Res; 2003 Nov; 93(11):1074-81. PubMed ID: 14576200
[TBL] [Abstract][Full Text] [Related]
13. Hypoxia-independent gene expression mediated by SOX9 promotes aggressive pancreatic tumor biology.
Camaj P; Jäckel C; Krebs S; De Toni EN; Blum H; Jauch KW; Nelson PJ; Bruns CJ
Mol Cancer Res; 2014 Mar; 12(3):421-32. PubMed ID: 24302456
[TBL] [Abstract][Full Text] [Related]
14. Tumor-derived vascular endothelial growth factor up-regulates angiopoietin-2 in host endothelium and destabilizes host vasculature, supporting angiogenesis in ovarian cancer.
Zhang L; Yang N; Park JW; Katsaros D; Fracchioli S; Cao G; O'Brien-Jenkins A; Randall TC; Rubin SC; Coukos G
Cancer Res; 2003 Jun; 63(12):3403-12. PubMed ID: 12810677
[TBL] [Abstract][Full Text] [Related]
15. Periostin mediates the increased pro-angiogenic activity of gastric cancer cells under hypoxic conditions.
Qiu F; Shi CH; Zheng J; Liu YB
J Biochem Mol Toxicol; 2013 Jul; 27(7):364-9. PubMed ID: 23728938
[TBL] [Abstract][Full Text] [Related]
16. HIF2-Induced Long Noncoding RNA RAB11B-AS1 Promotes Hypoxia-Mediated Angiogenesis and Breast Cancer Metastasis.
Niu Y; Bao L; Chen Y; Wang C; Luo M; Zhang B; Zhou M; Wang JE; Fang YV; Kumar A; Xing C; Wang Y; Luo W
Cancer Res; 2020 Mar; 80(5):964-975. PubMed ID: 31900259
[TBL] [Abstract][Full Text] [Related]
17. Analysis of hypoxia-related gene expression in sarcomas and effect of hypoxia on RNA interference of vascular endothelial cell growth factor A.
Detwiller KY; Fernando NT; Segal NH; Ryeom SW; D'Amore PA; Yoon SS
Cancer Res; 2005 Jul; 65(13):5881-9. PubMed ID: 15994966
[TBL] [Abstract][Full Text] [Related]
18. Nelumbo nucifera Gaertn leaves extract inhibits the angiogenesis and metastasis of breast cancer cells by downregulation connective tissue growth factor (CTGF) mediated PI3K/AKT/ERK signaling.
Chang CH; Ou TT; Yang MY; Huang CC; Wang CJ
J Ethnopharmacol; 2016 Jul; 188():111-22. PubMed ID: 27178635
[TBL] [Abstract][Full Text] [Related]
19. MUC1 mucin stabilizes and activates hypoxia-inducible factor 1 alpha to regulate metabolism in pancreatic cancer.
Chaika NV; Gebregiworgis T; Lewallen ME; Purohit V; Radhakrishnan P; Liu X; Zhang B; Mehla K; Brown RB; Caffrey T; Yu F; Johnson KR; Powers R; Hollingsworth MA; Singh PK
Proc Natl Acad Sci U S A; 2012 Aug; 109(34):13787-92. PubMed ID: 22869720
[TBL] [Abstract][Full Text] [Related]
20. Suppression of VEGF expression through interruption of the HIF‑1α and Akt signaling cascade modulates the anti‑angiogenic activity of DAPK in ovarian carcinoma cells.
Park ST; Kim BR; Park SH; Lee JH; Lee EJ; Lee SH; Rho SB
Oncol Rep; 2014 Feb; 31(2):1021-9. PubMed ID: 24337450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
